A tyrosine kinase inhibitor is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of many proteins by signal transduction cascades. From Wikipedia
Fueled by trial-proven high response rates alongside favorable safety, the new approval pairs an oral HER2-selective inhibitor with its companion diagnostic
